Clinical trial
Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent…
NCT00005839 · City of Hope Medical Center, Other · Completed
Key facts
| NCT number | NCT00005839 |
|---|---|
| Title | Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor |
| Official title | A Phase I Study of Oxaliplatin in Combination With Capecitabine in Metastatic/Recurrent Solid Tumors |
| Lead sponsor | City of Hope Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | capecitabine, oxaliplatin |
| Start date | Aug 1, 2000 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Apr 21, 2003 |
| Last update posted | Jun 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: